Assignee
UROGEN PHARMA LTD
IL·12 granted patents·15 pending applications·38 citations·filing 2013–2025
Top patents by PatentIndex Score
27 records- 0191US10471150B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2013·Granted Nov 12, 2019·9 cites·13 claims
- 0289US9950069B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2016·Granted Apr 24, 2018·10 cites·30 claims
- 0387US12268745B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2024·Granted Apr 8, 2025·0 cites·8 claims
- 0487US10039832B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2015·Granted Aug 7, 2018·7 cites·23 claims
- 0586US10758482B2Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2019·Granted Sep 1, 2020·3 cites·15 claims
- 0685US9540407B2Phospholipid drug analogsUROGEN PHARMA LTD·Filed 2015·Granted Jan 10, 2017·5 cites·18 claims
- 0782US2023241220A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 0882US2023241221A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 0982US2023233685A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 1079US12263245B2Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2024·Granted Apr 1, 2025·0 cites·21 claims
- 1178US12440568B2Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2025·Granted Oct 14, 2025·0 cites·10 claims
- 1278US2022118096A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2021·Application pending·0 cites
- 1377US10994109B2Connectable catheterUROGEN PHARMA LTD·Filed 2015·Granted May 4, 2021·4 cites·11 claims
- 1474US2020114008A1Material and method for treating internal cavitiesUROGEN PHARMA LTD·Filed 2019·Application pending·0 cites
- 1571US12171747B2Material and method for treating cancerUROGEN PHARMA LTD·Filed 2023·Granted Dec 24, 2024·0 cites·9 claims
- 1671US2023218521A1Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 1768US2025032409A1Treatment of low-grade intermediate-risk non-muscle-invasive bladder cancer with a thermally gelling pharmaceutical composition containing mitomycinUROGEN PHARMA LTD·Filed 2024·Application pending·0 cites
- 1864US12336979B2Material and method for treating cancerUROGEN PHARMA LTD·Filed 2021·Granted Jun 24, 2025·0 cites·6 claims
- 1963US2025221929A1Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2025·Application pending·0 cites
- 2062US2024100019A1Compositions comprising a thermoreversible hydrogel, and having an extended in-use periodUROGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 2161US2020397695A1Immunomodulating treatments of body cavitiesUROGEN PHARMA LTD·Filed 2020·Application pending·0 cites
- 2257US2020276183A1Pharmaceutical compositions comprising imiquimod for use in the treatment of carcinoma in situ of the bladderUROGEN PHARMA LTD·Filed 2019·Application pending·0 cites
- 2353US11576744B2Thermosensitive bio-adhesive hydrogel for removal of ureteral and renal stonesUROGEN PHARMA LTD·Filed 2022·Granted Feb 14, 2023·0 cites·20 claims
- 2453US2017266297A1Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administrationUROGEN PHARMA LTD·Filed 2017·Application pending·0 cites
- 2552US2017143833A1Production of thermoreversible hydrogels for therapeutic applicationsUROGEN PHARMA LTD·Filed 2017·Application pending·0 cites
- 2637US2019000667A1Connectable catheter systemUROGEN PHARMA LTD·Filed 2016·Application pending·0 cites
- 2734US2016331743A1Pharmaceutical compositions comprising imiquimod for use in the treatment of carcinoma in situ of the bladderUROGEN PHARMA LTD·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →